Awards & Achievements

Achievements Built on Innovation, Dedication, and Trust

Since its establishment, Arena Life Science has made remarkable progress in the pharmaceutical industry. Our dedication to innovation, quality, and patient care has earned us recognition at both national and industry levels. These awards and achievements reflect our commitment to advancing healthcare and building trust with patients, partners, and society.

Key Achievements

Establishing a Strong Foundation
  • Launch of R&D phase and initiation of selected drug manufacturing.
  • Entry of Rivaroxaban (Axabin) into the national drug list.
2014
First Breakthrough
  • Became the first Iranian manufacturer of the anticoagulant drug Rivaroxaban (Axabin).
  • Initiated R&D on Alteplase, one of the world’s most complex recombinant proteins.
2015
National Recognition
  • Officially recognized as a Knowledge-Based (Science-Based) Company, a title granted to only a few pharmaceutical firms in Iran.
  • Successfully launched Sitagliptin (Diaptin) for diabetes patients and Leflunomide (Lerava) for rheumatoid arthritis.
2016
Expanding Portfolio & Workforce
  • Launched Apixaban (Apirax), introduced for the first time in Iran.
  • Achieved success in completing R&D for recombinant products, registering scientific records and clinical trial documents with the IFDA.
  • Expanded human resources to over 90 employees in just four years.
2017
2018 to 2022
Sustained Growth
  • Continued expansion of workforce, achieving a 48-fold growth since establishment.
  • Strengthened market presence with a growing product portfolio and increased investment in biotechnology research.
2018
Recognition-and-Awards-Img

Recognition & Awards

  • Knowledge-Based Certificate (2016) A prestigious recognition for innovation and scientific contribution.
  • Industry Firsts Pioneer in producing several high-value pharmaceuticals locally, reducing reliance on imports.
  • Biotechnology Leadership Among the few Iranian companies conducting successful clinical research on recombinant proteins.
  • Human Capital Growth Award Recognition of our sustained investment in people and knowledge.

Looking Forward

These milestones are only the beginning. As we continue to grow, Arena Life Science remains committed to expanding its achievements by:

  • Bringing more innovative products to the market.
  • Strengthening partnerships at national and international levels.
  • Leading the way in biotechnology and pharmaceutical sustainability.